Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula

Get In Touch

Quick Email
info.help@gmail.com
  • Home |
  • RA Capital launches rare disease company Oak Hill Bio onto Nasdaq via SPAC

RA Capital launches rare disease company Oak Hill Bio onto Nasdaq via SPAC

  • July 27, 2026

Rare disease biotech Oak Hill is headed to the Nasdaq through a SPAC merger with RA Capital-sponsored Research Alliance Corporation III (RACC) to fund a rare genetic disease candidate.

Leave A Comment

Fields (*) Mark are Required